Guardant Health
GH
#1678
Rank
HK$96.46 B
Marketcap
HK$735.40
Share price
2.94%
Change (1 day)
117.40%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -HK$25.81

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$25.94. In 2024 the company made an earnings per share (EPS) of -HK$27.90 an increase over its 2023 EPS that were of -HK$33.54.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.81-7.5%
2024-HK$27.90-16.82%
2023-HK$33.54-33.13%
2022-HK$50.1660%
2021-HK$31.3555.04%
2020-HK$20.22207.14%
2019-HK$6.58-19.81%
2018-HK$8.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$21.77-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$16.77-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA